Robbie Marcus
Stock Analyst at J.P. Morgan
(4.38)
# 1,265
Out of 5,043 analysts
536
Total ratings
52.4%
Success rate
7.6%
Average return
Main Sectors:
Stocks Rated by Robbie Marcus
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Reiterated: Buy | $56 | $42.73 | +31.06% | 29 | Oct 1, 2026 | |
| COO The Cooper Companies | Rated: Hold | $71 → $58 | $54.37 | +6.68% | 21 | Sep 10, 2026 | |
| MDT Medtronic | Reiterated: Hold | $86 → $96 | $88.48 | +8.50% | 27 | Sep 3, 2026 | |
| ABT Abbott Laboratories | Reiterated: Buy | n/a | $99.60 | - | 19 | Sep 1, 2026 | |
| ZBH Zimmer Biomet Holdings | Reiterated: Hold | $95 → $117 | $89.14 | +31.25% | 18 | Aug 17, 2026 | |
| HTFL HeartFlow | Reiterated: Buy | $35 → $45 | $49.74 | -9.53% | 6 | Aug 14, 2026 | |
| MOBI Mobia Medical | Reiterated: Buy | $15 → $17 | $8.63 | +96.99% | 2 | Aug 12, 2026 | |
| BDX Becton, Dickinson and Company | Reiterated: Hold | $190 → $188 | $183.75 | +2.31% | 14 | Aug 10, 2026 | |
| ENOV Enovis | Reiterated: Hold | $33 → $28 | $17.69 | +58.28% | 6 | Aug 10, 2026 | |
| KMTS Kestra Medical Technologies | Initiated Coverage: Buy | $30 | $26.98 | +11.19% | 1 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $19 → $26 | $24.35 | +6.78% | 24 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $9 → $6 | $4.81 | +24.74% | 19 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $275 → $152 | $135.28 | +12.36% | 26 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $82 | $84.11 | -2.51% | 27 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $11 → $17 | $13.44 | +26.49% | 21 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $54 → $60 | $68.89 | -12.90% | 21 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 | $87.21 | +8.93% | 6 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $350 | $277.33 | +26.20% | 19 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $40 → $45 | $44.42 | +1.31% | 20 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $65 → $70 | $65.74 | +6.48% | 5 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $105 | $85.21 | +23.22% | 25 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $450 | $423.96 | +6.14% | 20 | Jul 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $6 | $1.58 | +279.75% | 16 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $275 → $370 | $319.40 | +15.84% | 25 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $17 | $23.63 | -28.06% | 5 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 → $16 | $17.30 | -7.51% | 13 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $9 → $7 | $6.18 | n/a | 27 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 → $7 | $13.07 | n/a | 8 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $51 | $55.81 | n/a | 20 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $9 → $14 | $12.67 | n/a | 10 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $15 → $8 | $3.95 | n/a | 7 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $80 → $85 | $165.69 | n/a | 13 | May 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $95 | $106.70 | n/a | 14 | Apr 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $34 | $77.87 | n/a | 1 | May 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $40 | $15.48 | n/a | 1 | Jun 8, 2018 |
Boston Scientific
Oct 1, 2026
Reiterated: Buy
Price Target: $56
Current: $42.73
Upside: +31.06%
The Cooper Companies
Sep 10, 2026
Rated: Hold
Price Target: $71 → $58
Current: $54.37
Upside: +6.68%
Medtronic
Sep 3, 2026
Reiterated: Hold
Price Target: $86 → $96
Current: $88.48
Upside: +8.50%
Abbott Laboratories
Sep 1, 2026
Reiterated: Buy
Price Target: n/a
Current: $99.60
Upside: -
Zimmer Biomet Holdings
Aug 17, 2026
Reiterated: Hold
Price Target: $95 → $117
Current: $89.14
Upside: +31.25%
HeartFlow
Aug 14, 2026
Reiterated: Buy
Price Target: $35 → $45
Current: $49.74
Upside: -9.53%
Mobia Medical
Aug 12, 2026
Reiterated: Buy
Price Target: $15 → $17
Current: $8.63
Upside: +96.99%
Becton, Dickinson and Company
Aug 10, 2026
Reiterated: Hold
Price Target: $190 → $188
Current: $183.75
Upside: +2.31%
Enovis
Aug 10, 2026
Reiterated: Hold
Price Target: $33 → $28
Current: $17.69
Upside: +58.28%
Kestra Medical Technologies
Aug 10, 2026
Initiated Coverage: Buy
Price Target: $30
Current: $26.98
Upside: +11.19%
Aug 6, 2026
Reiterated: Hold
Price Target: $19 → $26
Current: $24.35
Upside: +6.78%
Aug 6, 2026
Reiterated: Sell
Price Target: $9 → $6
Current: $4.81
Upside: +24.74%
Aug 5, 2026
Downgraded: Hold
Price Target: $275 → $152
Current: $135.28
Upside: +12.36%
Aug 4, 2026
Reiterated: Hold
Price Target: $82
Current: $84.11
Upside: -2.51%
Aug 4, 2026
Reiterated: Sell
Price Target: $11 → $17
Current: $13.44
Upside: +26.49%
Aug 4, 2026
Reiterated: Hold
Price Target: $54 → $60
Current: $68.89
Upside: -12.90%
Aug 4, 2026
Reiterated: Buy
Price Target: $95
Current: $87.21
Upside: +8.93%
Aug 4, 2026
Reiterated: Buy
Price Target: $350
Current: $277.33
Upside: +26.20%
Jul 30, 2026
Rated: Hold
Price Target: $40 → $45
Current: $44.42
Upside: +1.31%
Jul 30, 2026
Rated: Hold
Price Target: $65 → $70
Current: $65.74
Upside: +6.48%
Jul 28, 2026
Reiterated: Buy
Price Target: $105
Current: $85.21
Upside: +23.22%
Jul 21, 2026
Reiterated: Buy
Price Target: $450
Current: $423.96
Upside: +6.14%
May 12, 2026
Reiterated: Sell
Price Target: $6
Current: $1.58
Upside: +279.75%
Dec 18, 2025
Upgraded: Buy
Price Target: $275 → $370
Current: $319.40
Upside: +15.84%
Nov 5, 2025
Reiterated: Buy
Price Target: $21 → $17
Current: $23.63
Upside: -28.06%
Oct 30, 2025
Reiterated: Hold
Price Target: $13 → $16
Current: $17.30
Upside: -7.51%
Aug 8, 2025
Reiterated: Sell
Price Target: $9 → $7
Current: $6.18
Upside: n/a
May 6, 2025
Reiterated: Hold
Price Target: $13 → $7
Current: $13.07
Upside: n/a
Feb 11, 2025
Reiterated: Buy
Price Target: $40 → $51
Current: $55.81
Upside: n/a
Dec 17, 2024
Initiated Coverage: Buy
Price Target: $9 → $14
Current: $12.67
Upside: n/a
May 8, 2024
Downgraded: Hold
Price Target: $15 → $8
Current: $3.95
Upside: n/a
May 6, 2021
Reiterated: Sell
Price Target: $80 → $85
Current: $165.69
Upside: n/a
Apr 12, 2021
Downgraded: Hold
Price Target: $95
Current: $106.70
Upside: n/a
May 28, 2019
Initiated Coverage: Buy
Price Target: $34
Current: $77.87
Upside: n/a
Jun 8, 2018
Upgraded: Buy
Price Target: $40
Current: $15.48
Upside: n/a